Publications by authors named "Matthieu Boucher"

Claim this Profile
R
Role of serotonin in psychiatric and somatic comorbidities of attention-deficit/hyperactivity disorder: a systematic literature review.
Stephen V Faraone, Caroline L Ward, Matthieu Boucher, Reem Elbekai, Elizabeth Brunner

Neurosci Biobehav Rev· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of serotonin in the neurobiology of attention-deficit/hyperactivity disorder: a systematic literature review.
Stephen V Faraone, Caroline L Ward, Matthieu Boucher, Reem Elbekai, Elizabeth Brunner

Expert Opin Ther Targets· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urgency to treat and early optimized treatment in major depressive disorder: consequences of delayed treatment, barriers to implementation, and practical strategies for clinicians.
Oloruntoba J Oluboka, Jeffrey Habert, Atul Khullar, David J Robinson, Martin A Katzman, Matthieu Boucher

CNS Spectr· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness of aripiprazole once monthly on functioning and quality of life in schizophrenia: results of year 2 of the ReLiAM study.
Marc-André Roy, François Therrien, Matthieu Boucher, Oloruntoba Oluboka

BMC Psychiatry· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress: Post Hoc Analysis of Three Placebo-Controlled Studies.
Roger S McIntyre, Suzy Bubolic, Zhen Zhang, Erin M MacKenzie, François Therrien, Matthieu Boucher

J Clin Psychopharmacol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use - a post hoc analysis of the ReLiAM study.
Howard C Margolese, Matthieu Boucher, Francois Therrien, Guerline Clerzius

BMC Psychiatry· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of adjunctive brexpiprazole on symptom clusters of major depressive disorder: A post hoc analysis of four clinical studies.
Martin A Katzman, François Therrien, Erin M MacKenzie, Fan Wang, Anne de Jong-Laird, Matthieu Boucher

J Affect Disord· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectories of Function and Symptom Change in Desvenlafaxine Clinical Trials: Toward Personalized Treatment for Depression.
Sigal Zilcha-Mano, Xuemei Wang, Dalia B Wajsbrot, Matthieu Boucher, Stuart A Fine

J Clin Psychopharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clustering patients by depression symptoms to predict venlafaxine ER antidepressant efficacy: Individual patient data analysis.
Masaki Kato, Yuko Asami, Dalia B Wajsbrot, Xuemei Wang, Matthieu Boucher

J Psychiatr Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of functional response and remission with desvenlafaxine 50 mg and 100 mg: a pooled analysis of randomized, placebo-controlled studies in patients with major depressive disorder.
Claudio N Soares, Dalia B Wajsbrot, Matthieu Boucher

CNS Spectr· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of desvenlafaxine versus placebo on MDD symptom clusters: A pooled analysis.
Martin A Katzman, Xuemei Wang, Dalia B Wajsbrot, Matthieu Boucher

J Psychopharmacol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study.
Roger S McIntyre, Rita Prieto, Patricia Schepman, Yu-Chen Yeh, Matthieu Boucher

Curr Med Res Opin· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Categorical improvement in functional impairment in depressed patients treated with desvenlafaxine.
Claudio N Soares, Min Zhang, Matthieu Boucher

CNS Spectr· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching medication products during the treatment of psychiatric illness.
Pierre Blier, Howard C Margolese, E Adriana Wilson, Matthieu Boucher

Int J Psychiatry Clin Pract· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue selective estrogen complex (TSEC): a review.
James H Pickar, Matthieu Boucher, Diana Morgenstern

Menopause· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder.
Martin A Katzman, Andrew A Nierenberg, Dalia B Wajsbrot, Ellen Meier, Rita Prieto, Matthieu Boucher

J Clin Psychopharmacol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term function and psychosocial outcomes with venlafaxine extended release 75-225 mg/day versus placebo in the PREVENT study.
Koichiro Watanabe, Michael E Thase, Toshiaki Kikuchi, Takashi Tsuboi, Yuko Asami, Matthieu Boucher

Int Clin Psychopharmacol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of desvenlafaxine 50 mg and 100 mg on energy and lassitude in patients with major depressive disorder: A pooled analysis.
Raymond W Lam, Dalia B Wajsbrot, Ellen Meier, Elizabeth Pappadopulos, Joan A Mackell, Matthieu Boucher

J Psychopharmacol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoring function in major depressive disorder: A systematic review.
David V Sheehan, Kazuyuki Nakagome, Yuko Asami, Elizabeth A Pappadopulos, Matthieu Boucher

J Affect Disord· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Desvenlafaxine Compared With Placebo in Major Depressive Disorder Patients by Age Group and Severity of Depression at Baseline.
Daniel Mosca, Min Zhang, Rita Prieto, Matthieu Boucher

J Clin Psychopharmacol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder.
Michael Thase, Yuko Asami, Dalia Wajsbrot, Kathleen Dorries, Matthieu Boucher

Curr Med Res Opin· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of metabolic syndrome and thyroid hormone on efficacy of desvenlafaxine 50 and 100 mg/d in major depressive disorder.
Roger S McIntyre, Rana Fayyad, Joan A Mackell, Matthieu Boucher

Curr Med Res Opin· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder.
José L Carrasco, Susan G Kornstein, Roger S McIntyre, Rana Fayyad, Rita Prieto, Matthieu Boucher

Int Clin Psychopharmacol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of conjugated estrogens/bazedoxifene therapy on body weight of postmenopausal women: pooled analysis of five randomized, placebo-controlled trials.
Denise Black, Michael Messig, Ching-Ray Yu, Annlouise R Assaf, Barry S Komm, Matthieu Boucher

Menopause· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Post Hoc Analysis of the Effect of Weight on Efficacy in Depressed Patients Treated With Desvenlafaxine 50 mg/d and 100 mg/d.
Roger S McIntyre, Rana S Fayyad, Christine J Guico-Pabia, Matthieu Boucher

Prim Care Companion CNS Disord· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis